By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


SAGE Therapeutics 

29 Newbury Street

Boston  Massachusetts  02116  U.S.A.
Phone: n/a Fax: n/a



Start Up

Company News
SAGE Therapeutics (SAGE) Announces Proposed Public Offering Of Common Stock 1/6/2016 10:28:22 AM
Decibel Therapeutics Appoints Jeff Jonas, M.D., CEO Of SAGE Therapeutics (SAGE), To Its Board Of Directors 12/16/2015 10:26:38 AM
Christmas Comes Early to SAGE Therapeutics (SAGE) Investors as Company Accelerates Promising Pipeline Timeline 12/16/2015 6:37:35 AM
SAGE Therapeutics (SAGE) To Present Three Poster Presentations At The American Epilepsy Society 69th Annual Meeting 12/2/2015 10:46:13 AM
SAGE Therapeutics (SAGE) To Present At The Piper Jaffray 27th Annual Healthcare Conference 11/25/2015 7:49:15 AM
Ligand (LGND) Expands Captisol License And Supply Agreements With SAGE Therapeutics (SAGE) To Include SAGE-689 9/29/2015 10:37:35 AM
SAGE Therapeutics (SAGE) To Participate In The 4th Annual Leerink Partners Rare Disease Roundtable 9/23/2015 8:46:52 AM
SAGE Therapeutics (SAGE) Expands Leadership Team With Key Appointments 9/21/2015 8:34:24 AM
SAGE Therapeutics (SAGE) Committs to Fighting Tremors After Lead Drug Shines in Small Study 9/3/2015 5:51:28 AM
SAGE Therapeutics (SAGE) Announces First Patient Treated In Phase III STATUS Trial Of SAGE-547 In Super-Refractory Status Epilepticus 8/17/2015 5:58:29 AM